Abstract
Antibiotic-resistant Burkholderia cepacia is an important pathogen in cystic fibrosis. We have previously shown enhanced tobramycin susceptibility of most strains in the presence of the drug amiloride. Others have shown similar findings in the presence of cationic agents with amine groups. To examine the relationship of substituted amine drug structure and synergy potential with tobramycin, the in vitro activity of 45 non-antibiotic substituted amine and related compounds in the presence and absence of tobramycin was studied. Very few agents had intrinsic antimicrobial action but many were very synergistic with tobramycin. Dichloroisoproterenol and propranolol were the most synergistic. Sympathomimetic, imidazoline agents, phenothiazenes, and thioxanthenes varied greatly. Exploration of these compounds may provide an avenue for treating antibiotic-resistant B. cepacia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
